Alan Howard

5.4k total citations
93 papers, 3.1k citations indexed

About

Alan Howard is a scholar working on Biochemistry, Molecular Biology and Hematology. According to data from OpenAlex, Alan Howard has authored 93 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Biochemistry, 19 papers in Molecular Biology and 19 papers in Hematology. Recurrent topics in Alan Howard's work include Antioxidant Activity and Oxidative Stress (26 papers), Retinal Diseases and Treatments (16 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Alan Howard is often cited by papers focused on Antioxidant Activity and Oxidative Stress (26 papers), Retinal Diseases and Treatments (16 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Alan Howard collaborates with scholars based in United Kingdom, United States and Ireland. Alan Howard's co-authors include John M. Nolan, G. A. Gresham, David I. Thurnham, Stephen Beatty, Norman Williams, Shailja Nigdikar, Bruce A. Griffin, Ríona Mulcahy, Rachel Moran and Jim Stack and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Alan Howard

88 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Howard United Kingdom 34 1.1k 701 544 461 390 93 3.1k
Seyithan Tayşi Türkiye 37 248 0.2× 1.0k 1.4× 679 1.2× 97 0.2× 456 1.2× 166 4.5k
Francisco J. Romero Spain 37 268 0.3× 1.3k 1.9× 583 1.1× 709 1.5× 466 1.2× 120 4.4k
Donald E. Smith United States 39 1.0k 1.0× 2.2k 3.1× 640 1.2× 63 0.1× 892 2.3× 143 5.5k
Yuzo Sato Japan 33 357 0.3× 1.1k 1.6× 1.3k 2.4× 173 0.4× 321 0.8× 164 4.3k
Hüseyın Özyurt Türkiye 35 175 0.2× 873 1.2× 510 0.9× 109 0.2× 368 0.9× 102 4.0k
D. P. R. Muller United Kingdom 35 1.0k 1.0× 1.1k 1.6× 369 0.7× 48 0.1× 1.1k 2.8× 106 3.4k
Francisco Bosch‐Morell Spain 30 271 0.3× 669 1.0× 297 0.5× 668 1.4× 232 0.6× 75 2.4k
Richard Draijer Netherlands 30 640 0.6× 775 1.1× 811 1.5× 31 0.1× 320 0.8× 61 3.1k
Georg Lietz United Kingdom 29 1.1k 1.0× 978 1.4× 501 0.9× 32 0.1× 924 2.4× 73 3.0k
Fatih Akçay Türkiye 31 150 0.1× 600 0.9× 425 0.8× 57 0.1× 351 0.9× 133 3.1k

Countries citing papers authored by Alan Howard

Since Specialization
Citations

This map shows the geographic impact of Alan Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Howard more than expected).

Fields of papers citing papers by Alan Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Howard. The network helps show where Alan Howard may publish in the future.

Co-authorship network of co-authors of Alan Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Howard. A scholar is included among the top collaborators of Alan Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Howard. Alan Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ngankeu, Apollinaire, et al.. (2019). Serum MicroRNA-155 in Acute Graft-Versus-Host-Disease (aGVHD). PubMed. 2(1). 79–82. 1 indexed citations
3.
Newell, Laura F., Todd E. DeFor, Corey Cutler, et al.. (2019). Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(3). 606–611. 4 indexed citations
4.
Kelly, David, John M. Nolan, Alan Howard, et al.. (2017). Serum and macular response to carotenoid-enriched egg supplementation in human subjects: the Egg Xanthophyll Intervention clinical Trial (EXIT). British Journal Of Nutrition. 117(1). 108–123. 14 indexed citations
5.
Holtan, Shernan G., Laura F. Newell, Corey Cutler, et al.. (2017). Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402. Bone Marrow Transplantation. 52(9). 1300–1303. 9 indexed citations
6.
Hope, William, Thomas J. Walsh, Joanne Goodwin, et al.. (2016). Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial. Journal of Antimicrobial Chemotherapy. 71(8). 2234–2240. 9 indexed citations
7.
Beatty, Stephen, Eithne Connolly, James Loughman, et al.. (2014). SUPPLEMENTATION WITH THREE DIFFERENT MACULAR CAROTENOID FORMULATIONS IN PATIENTS WITH EARLY AGE-RELATED MACULAR DEGENERATION. Retina. 34(9). 1757–1766. 43 indexed citations
8.
Nolan, John M., Ekaterina Loskutova, Alan Howard, et al.. (2014). Macular Pigment, Visual Function, and Macular Disease among Subjects with Alzheimer's Disease: An Exploratory Study. Journal of Alzheimer s Disease. 42(4). 1191–1202. 84 indexed citations
9.
Thurnham, David I. & Alan Howard. (2013). Studies on meso-zeaxanthin for potential toxicity and mutagenicity. Food and Chemical Toxicology. 59. 455–463. 16 indexed citations
10.
Loughman, James, Stephen Beatty, Alan Howard, Eithne Connolly, & John M. Nolan. (2012). Effect Of Carotenoid Supplementation On Macular Pigment Optical Density And Visual Performance In Normal Observers: The Most Vision Trial. Investigative Ophthalmology & Visual Science. 53(14). 3376–3376.
11.
Loughman, James, et al.. (2012). The Impact of Macular Pigment Augmentation on Visual Performance Using Different Carotenoid Formulations. Investigative Ophthalmology & Visual Science. 53(12). 7871–7880. 98 indexed citations
12.
Nolan, John M., Mukunda C. Akkali, James Loughman, Alan Howard, & Stephen Beatty. (2012). Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. Experimental Eye Research. 101. 9–15. 41 indexed citations
13.
Thurnham, David I., et al.. (2008). A supplementation study in human subjects with a combination ofmeso-zeaxanthin, (3R,3′R)-zeaxanthin and (3R,3′R,6′R)-lutein. British Journal Of Nutrition. 100(6). 1307–1314. 17 indexed citations
14.
McMorris, Terry, et al.. (2006). Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior. Physiology & Behavior. 90(1). 21–28. 73 indexed citations
15.
Hurley, Carolyn Katovich, Michelle Setterholm, M. Lau, et al.. (2003). Hematopoietic stem cell donor registry strategies for assigning search determinants and matching relationships. Bone Marrow Transplantation. 33(4). 443–450. 33 indexed citations
16.
Blann, Andrew D., Norman Williams, Gregory Y.H. Lip, J. Rajput-Williams, & Alan Howard. (2002). Acute ingestion of red wine by men activates platelets but does not influence endothelial markers: no effect of white wine. Blood Coagulation & Fibrinolysis. 13(7). 647–651. 4 indexed citations
17.
González, Félix, et al.. (2000). Beneficios de una dieta de muy bajas calorías: experiencia cubana durante 8 semanas (1998). SHILAP Revista de lepidopterología. 1 indexed citations
18.
Faughnan, Marian S., et al.. (2000). Plasma Diamine Oxidase Activity Is Greater in Copper-Adequate than Copper-Marginal or Copper-Deficient Rats. Journal of Nutrition. 130(1). 30–33. 27 indexed citations
19.
Nigdikar, Shailja, Norman Williams, Bruce A. Griffin, & Alan Howard. (1998). Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. American Journal of Clinical Nutrition. 68(2). 248–255. 279 indexed citations
20.
Howard, Alan, et al.. (1968). Recent advances in atherosclerosis. KARGER eBooks. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seyithan Tayşi Breakdown of academic impact, for papers by Francisco J. Romero Breakdown of academic impact, for papers by Donald E. Smith Breakdown of academic impact, for papers by Yuzo Sato Breakdown of academic impact, for papers by Hüseyın Özyurt Breakdown of academic impact, for papers by D. P. R. Muller Breakdown of academic impact, for papers by Francisco Bosch‐Morell Breakdown of academic impact, for papers by Richard Draijer Breakdown of academic impact, for papers by Georg Lietz Breakdown of academic impact, for papers by Fatih Akçay
Rankless by CCL
2026